BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu GL, Tong AST, Conole D, Sutherland HS, Choi PJ, Franzblau SG, Upton AM, Lotlikar MU, Cooper CB, Denny WA, Palmer BD. Synthesis and structure-activity relationships for tetrahydroisoquinoline-based inhibitors of Mycobacterium tuberculosis. Bioorg Med Chem 2020;28:115784. [PMID: 33007562 DOI: 10.1016/j.bmc.2020.115784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Denny WA. Inhibitors of F1F0-ATP synthase enzymes for the treatment of tuberculosis and cancer. Future Med Chem 2021;13:911-26. [PMID: 33845594 DOI: 10.4155/fmc-2021-0010] [Reference Citation Analysis]
2 Sutherland HS, Lu GL, Tong AST, Conole D, Franzblau SG, Upton AM, Lotlikar MU, Cooper CB, Palmer BD, Choi PJ, Denny WA. Synthesis and structure-activity relationships for a new class of tetrahydronaphthalene amide inhibitors of Mycobacterium tuberculosis. Eur J Med Chem 2021;229:114059. [PMID: 34963068 DOI: 10.1016/j.ejmech.2021.114059] [Reference Citation Analysis]
3 Faheem, Karan Kumar B, Chandra Sekhar KVG, Chander S, Kunjiappan S, Murugesan S. Medicinal chemistry perspectives of 1,2,3,4-tetrahydroisoquinoline analogs - biological activities and SAR studies. RSC Adv 2021;11:12254-87. [PMID: 35423735 DOI: 10.1039/d1ra01480c] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 10.0] [Reference Citation Analysis]
4 Dhameliya TM, Bhakhar KA, Gajjar ND, Patel KA, Devani AA, Hirani RV. Recent advancements and developments in search of anti-tuberculosis agents: A quinquennial update and future directions. Journal of Molecular Structure 2022;1248:131473. [DOI: 10.1016/j.molstruc.2021.131473] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
5 Choi PJ, Lu G, Sutherland HS, Giddens AC, Franzblau SG, Cooper CB, Denny WA, Palmer BD. Synthetic studies towards isomeric pyrazolopyrimidines as potential ATP synthesis inhibitors of Mycobacterium tuberculosis. Structural correction of reported N-(6-(2-(dimethylamino)ethoxy)-5-fluoropyridin-3-yl)-2-(4-fluorophenyl)-5-(trifluoromethyl)pyrazolo[1,5-α]pyrimidin-7-amine. Tetrahedron Letters 2021. [DOI: 10.1016/j.tetlet.2021.153611] [Reference Citation Analysis]